Suppr超能文献

分析发育和成熟肾脏的三维系统,阐明了 OAT1 和 OAT3 在抗病毒处理中的作用。

Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling.

机构信息

Department of Pediatrics, University of California San Diego, La Jolla, California 92093, USA.

出版信息

J Biol Chem. 2011 Jan 7;286(1):243-51. doi: 10.1074/jbc.M110.139949. Epub 2010 Oct 4.

Abstract

The organic anion transporters OAT1 (SLC22A6, originally identified by us as NKT) and OAT3 (SLC22A8) are critical for handling many toxins, metabolites, and drugs, including antivirals (Truong, D. M., Kaler, G., Khandelwal, A., Swaan, P. W., and Nigam, S. K. (2008) J. Biol. Chem. 283, 8654-8663). Although microinjected Xenopus oocytes and/or transfected cells indicate overlapping specificities, the individual contributions of these transporters in the three-dimensional context of the tissues in which they normally function remain unclear. Here, handling of HIV antivirals (stavudine, tenofovir, lamivudine, acyclovir, and zidovudine) was analyzed with three-dimensional ex vivo functional assays using knock-out tissue. To investigate the contribution of OAT1 and OAT3 in various nephron segments, the OAT-selective fluorescent tracer substrates 5-carboxyfluorescein and 6-carboxyfluorescein were used. Although OAT1 function (uptake in oat3(-/-) tissue) was confined to portions of the cortex, consistent with a proximal tubular localization, OAT3 function (uptake in oat1(-/-) tissue) was apparent throughout the cortex, indicating localization in the distal as well as proximal nephron. This functional localization indicates a complex three-dimensional context, which needs to be considered for metabolites, toxins, and drugs (e.g. antivirals) handled by both transporters. These results also raise the possibility of functional differences in the relative importance of OAT1 and OAT3 in antiviral handling in developing and mature tissue. Because the HIV antivirals are used in pregnant women, the results may also help in understanding how these drugs are handled by developing organs.

摘要

有机阴离子转运体 OAT1(SLC22A6,最初由我们鉴定为 NKT)和 OAT3(SLC22A8)对于处理许多毒素、代谢物和药物,包括抗病毒药物(Truong,D.M.,Kaler,G.,Khandelwal,A.,Swaan,P.W.和 Nigam,S.K.(2008)J.Biol.Chem.283,8654-8663)至关重要。尽管微注射 Xenopus 卵母细胞和/或转染细胞表明存在重叠的特异性,但这些转运体在其正常功能的组织的三维环境中的个体贡献仍不清楚。在这里,使用敲除组织的三维离体功能测定法分析了 HIV 抗病毒药物(司他夫定、替诺福韦、拉米夫定、阿昔洛韦和齐多夫定)的处理。为了研究 OAT1 和 OAT3 在各种肾单位段中的贡献,使用 OAT 选择性荧光示踪底物 5-羧基荧光素和 6-羧基荧光素。尽管 OAT1 功能(在 oat3(-/-)组织中的摄取)仅限于皮质部分,与近端肾小管定位一致,但 OAT3 功能(在 oat1(-/-)组织中的摄取)在整个皮质中都很明显,表明在远端和近端肾单位中都有定位。这种功能定位表明存在复杂的三维环境,对于代谢物、毒素和药物(例如抗病毒药物)的处理都需要考虑到这种环境。这些结果还表明,在处理抗病毒药物方面,OAT1 和 OAT3 的相对重要性在发育中和成熟组织中可能存在功能差异。由于这些抗病毒药物在孕妇中使用,因此这些结果也可能有助于理解这些药物在发育器官中的处理方式。

相似文献

2
Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.
Neurosci Lett. 2013 Feb 8;534:133-8. doi: 10.1016/j.neulet.2012.11.027. Epub 2012 Nov 27.
4
Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics.
Am J Physiol Renal Physiol. 2008 Apr;294(4):F867-73. doi: 10.1152/ajprenal.00528.2007. Epub 2008 Jan 23.
5
Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
J Biol Chem. 2021 Jan-Jun;296:100575. doi: 10.1016/j.jbc.2021.100575. Epub 2021 Mar 21.
6
Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
J Biol Chem. 2020 Feb 14;295(7):1829-1842. doi: 10.1074/jbc.RA119.010729. Epub 2020 Jan 2.
7
A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.
Am J Physiol Renal Physiol. 2012 May 15;302(10):F1293-9. doi: 10.1152/ajprenal.00013.2012. Epub 2012 Feb 15.
8
The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis.
J Biol Chem. 2017 Sep 22;292(38):15789-15803. doi: 10.1074/jbc.M117.796516. Epub 2017 Aug 1.
9
The flounder organic anion transporter fOat has sequence, function, and substrate specificity similarity to both mammalian Oat1 and Oat3.
Am J Physiol Regul Integr Comp Physiol. 2006 Dec;291(6):R1773-80. doi: 10.1152/ajpregu.00326.2006. Epub 2006 Jul 20.
10
Interaction of organic cations with organic anion transporters.
J Biol Chem. 2009 Nov 6;284(45):31422-30. doi: 10.1074/jbc.M109.024489. Epub 2009 Sep 8.

引用本文的文献

1
Integrating natural products with modern medicine in the treatment of gouty arthritis: a review.
Inflammopharmacology. 2025 May 26. doi: 10.1007/s10787-025-01784-0.
4
Construction and Evaluation of a Novel Organic Anion Transporter 1/3 CRISPR/Cas9 Double-Knockout Rat Model.
Pharmaceutics. 2022 Oct 27;14(11):2307. doi: 10.3390/pharmaceutics14112307.
5
The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.
Toxins (Basel). 2022 Feb 26;14(3):177. doi: 10.3390/toxins14030177.
6
Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3.
J Biol Chem. 2021 Jan-Jun;296:100575. doi: 10.1016/j.jbc.2021.100575. Epub 2021 Mar 21.
7
(-)-Epigallocatechin-3-gallate Inhibits Human and Rat Renal Organic Anion Transporters.
ACS Omega. 2021 Feb 2;6(6):4347-4354. doi: 10.1021/acsomega.0c05586. eCollection 2021 Feb 16.
8
Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.
J Biol Chem. 2020 Feb 14;295(7):1829-1842. doi: 10.1074/jbc.RA119.010729. Epub 2020 Jan 2.
9
Overview of organic anion transporters and organic anion transporter polypeptides and their roles in the liver.
World J Clin Cases. 2019 Dec 6;7(23):3915-3933. doi: 10.12998/wjcc.v7.i23.3915.
10
Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.
Acta Pharmacol Sin. 2020 Jan;41(1):129-137. doi: 10.1038/s41401-019-0283-z. Epub 2019 Jul 24.

本文引用的文献

1
Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology.
Biopharm Drug Dispos. 2010 Jan;31(1):1-71. doi: 10.1002/bdd.693.
3
Organic anion transporter 3 contributes to the regulation of blood pressure.
J Am Soc Nephrol. 2008 Sep;19(9):1732-40. doi: 10.1681/ASN.2008020180. Epub 2008 May 28.
5
Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues.
Nat Clin Pract Nephrol. 2007 Aug;3(8):443-8. doi: 10.1038/ncpneph0558.
7
Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2).
Pharm Res. 2007 Apr;24(4):811-5. doi: 10.1007/s11095-006-9196-x. Epub 2007 Feb 15.
8
Mechanism of active renal tubular efflux of tenofovir.
Antimicrob Agents Chemother. 2006 Oct;50(10):3297-304. doi: 10.1128/AAC.00251-06.
9
[Tubular transporters OAT1 and MRP2 and clearance of adefovir].
Nephrol Ther. 2005 Nov;1(5):296-300. doi: 10.1016/j.nephro.2005.06.011. Epub 2005 Oct 21.
10
Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.
Pediatr Nephrol. 2006 Jul;21(7):1034-6. doi: 10.1007/s00467-006-0109-3. Epub 2006 May 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验